Physiological Biomarkers Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Physiological Biomarkers. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Physiological Biomarkers Indian Medical PG Question 1: Specificity of a diagnostic test is defined as:
- A. 0.95 (Correct Answer)
- B. 0.05
- C. 0.4
- D. 0.8
Physiological Biomarkers Explanation: ***0.95***
- **Specificity** is the proportion of individuals without disease who test negative, calculated as **TN/(TN+FP)**.
- A specificity of 0.95 (95%) indicates an excellent test that correctly identifies 95% of healthy individuals as negative.
*0.05*
- This value represents the **false positive rate** (1 - specificity), not specificity itself.
- A specificity of 0.05 would mean only 5% of healthy individuals test negative, indicating a very poor test.
*0.4*
- This value is too low for specificity and could represent other test parameters like **positive predictive value**.
- A specificity of 0.4 would incorrectly classify 60% of healthy individuals as positive, making the test clinically unreliable.
*0.8*
- This value typically represents **sensitivity**, which is the proportion of diseased individuals who test positive.
- **Sensitivity** is calculated as **TP/(TP+FN)**, which is different from specificity that focuses on healthy individuals.
Physiological Biomarkers Indian Medical PG Question 2: Which of the following best reflects the diagnostic power of a test?
- A. Sensitivity and specificity (Correct Answer)
- B. Specificity alone
- C. Population attributable risk of a test
- D. Predictive value of a test
Physiological Biomarkers Explanation: ***Sensitivity and specificity***
- **Diagnostic power of a test** refers to its intrinsic ability to correctly identify individuals with and without disease, which is best reflected by **sensitivity and specificity**.
- **Sensitivity** (true positive rate) measures the test's power to detect disease when present - the ability to correctly identify diseased individuals.
- **Specificity** (true negative rate) measures the test's power to rule out disease when absent - the ability to correctly identify non-diseased individuals.
- These are **inherent properties of the test** that remain constant regardless of disease prevalence in the population, making them the true measures of diagnostic power.
- Together, they define how well a test can discriminate between diseased and non-diseased states.
*Predictive value of a test*
- **Predictive values** (positive and negative) indicate the probability of disease given a test result, but they are measures of **clinical utility**, not diagnostic power.
- Predictive values are **dependent on disease prevalence** - the same test with identical sensitivity and specificity will have different predictive values in populations with different disease prevalence.
- They answer "Given this result, what is the probability of disease?" rather than measuring the test's inherent diagnostic ability.
*Specificity alone*
- **Specificity alone** is incomplete as it only measures the test's ability to identify non-diseased individuals.
- Diagnostic power requires assessment of both the ability to detect disease (sensitivity) and to rule it out (specificity).
*Population attributable risk of a test*
- **Population attributable risk (PAR)** is an epidemiological measure that quantifies the proportion of disease in a population attributable to a specific risk factor.
- It is not a measure of diagnostic test performance and is unrelated to diagnostic power.
Physiological Biomarkers Indian Medical PG Question 3: Mr. Murali has 126 mg/dl of fasting plasma glucose. His venous plasma glucose 2h after ingestion of 75g oral glucose load is 149 mg/dl. This patient comes under which stage of WHO diagnostic criteria of diabetes & intermediate hyperglycemia?
- A. Decreased glucose resistance
- B. IFG - Impaired fasting glucose
- C. Diagnosis of diabetes (Correct Answer)
- D. Impaired glucose tolerance
Physiological Biomarkers Explanation: **Diagnosis of diabetes**
- The **fasting plasma glucose (FPG)** of 126 mg/dL meets the WHO criterion for **diabetes**, which is FPG ≥ 126 mg/dL [1].
- Although the 2-hour post-glucose load (149 mg/dL) falls within the **impaired glucose tolerance (IGT)** range (140-199 mg/dL), the elevated fasting glucose alone is sufficient for a diabetes diagnosis according to WHO guidelines.
*Decreased glucose resistance*
- This term is not a standard diagnostic category recognized by the WHO for glucose metabolism disorders.
- Glucose resistance is more commonly associated with conditions like **insulin resistance** rather than a specific diagnostic stage [1].
*IFG - Impaired fasting glucose*
- **Impaired fasting glucose (IFG)** is defined by a fasting plasma glucose level between 100 mg/dL and 125 mg/dL.
- Mr. Murali's fasting glucose of 126 mg/dL is higher than the upper limit for IFG [1].
*Impaired glucose tolerance*
- **Impaired glucose tolerance (IGT)** is defined by a 2-hour post-glucose load plasma glucose level between 140 mg/dL and 199 mg/dL.
- While Mr. Murali's 2-hour reading of 149 mg/dL falls within this range, the elevated fasting glucose level takes precedence for the overall diagnosis [1].
Physiological Biomarkers Indian Medical PG Question 4: What is the most sensitive biochemical marker for a 7-day old myocardial infarction?
- A. CPK MB
- B. LDH
- C. Myoglobin
- D. Troponin I/T (Correct Answer)
Physiological Biomarkers Explanation: ***Troponin I/T***
- **Cardiac troponins (I and T)** are highly sensitive and specific biomarkers for **myocardial injury**.
- While they rise quickly after an MI, they also remain elevated for an extended period, typically **7 to 10-14 days**, making them ideal for detecting a 7-day-old event.
*CPK MB*
- **Creatine phosphokinase MB (CPK-MB)** is a well-known cardiac marker, but its elevation is more transient, usually returning to normal within **2-3 days** post-MI.
- Therefore, it would likely be undetectable or near baseline 7 days after the event, making it insensitive for this duration.
*LDH*
- **Lactate dehydrogenase (LDH)** used to be used as a cardiac marker, but it is **non-specific** and found in various tissues.
- While it can remain elevated for an extended period after an MI (up to 10-14 days), its lack of specificity makes other markers, particularly troponins, much more reliable for confirming myocardial damage.
*Myoglobin*
- **Myoglobin** is one of the earliest markers to rise after myocardial injury, but it is also **rapidly cleared** from the bloodstream, usually within 24 hours.
- Due to its short half-life, myoglobin would not be elevated 7 days after an MI, making it unsuitable for detecting such a remote event.
Physiological Biomarkers Indian Medical PG Question 5: Okuda staging contains all except
- A. AFP (Correct Answer)
- B. Tumor size
- C. Ascites
- D. Bilirubin
Physiological Biomarkers Explanation: ***AFP***
- The **Okuda staging system** for hepatocellular carcinoma (HCC) uses parameters related to liver function and tumor burden, but it does **not include AFP levels**. [1]
- AFP is a common **tumor marker** for HCC but is not part of the specific criteria for Okuda staging.
*Tumor size*
- **Tumor size greater than 50%** of the liver parenchyma is one of the four parameters used in the Okuda staging system.
- This criterion is crucial for assessing the **extent of the disease**, differentiating between early and advanced cases.
*Ascites*
- The presence of **ascites** (related to fluid retention) is another key parameter in the Okuda staging system.
- Ascites indicates **decompensated liver function**, implying a more advanced stage of disease.
*Bilirubin*
- **Bilirubin levels higher than 3 mg/dL** are included in the Okuda staging system.
- Elevated bilirubin reflects **severe liver dysfunction**, indicating reduced hepatic synthetic capacity and usually a poorer prognosis.
Physiological Biomarkers Indian Medical PG Question 6: Cystatin C levels are used for
- A. Detecting UTI
- B. Estimating GFR (Correct Answer)
- C. Screening for Renal Ca
- D. Estimating difference between CRF and ARF
Physiological Biomarkers Explanation: ***Estimating GFR***
- **Cystatin C** is a **proteinase inhibitor** produced by all nucleated cells at a constant rate, and its level in the blood is inversely related to the **glomerular filtration rate (GFR)**.
- Unlike **creatinine**, Cystatin C levels are less affected by **muscle mass, diet, or inflammation**, making it a more reliable marker for early and subtle changes in GFR, especially in certain populations.
*Detecting UTI*
- **Urinary tract infections (UTIs)** are primarily detected through **urinalysis** (presence of **leukocytes, nitrites**, and **bacteria**) and **urine culture**.
- **Cystatin C** is a serum marker for renal function and has no direct role in detecting the presence of bacterial infection in the urinary tract.
*Estimating difference between CRF and ARF*
- Differentiating between **chronic renal failure (CRF)** and **acute renal failure (ARF)** typically involves assessing the **chronicity of symptoms**, trend in **creatinine levels**, and **kidney size** and **echogenicity** on ultrasound.
- While Cystatin C can reflect current GFR, it doesn't inherently provide discriminatory power between acute and chronic processes without serial measurements or additional clinical context.
*Screening for Renal Ca*
- **Renal cell carcinoma (RCC)** screening is primarily done using **imaging techniques** like **ultrasonography, CT, or MRI**, especially in individuals with risk factors or symptoms like **hematuria**.
- **Cystatin C** is a marker of kidney function and does not serve as a tumor marker for renal cancer.
Physiological Biomarkers Indian Medical PG Question 7: Procalcitonin is considered a marker for:
- A. Sepsis (Correct Answer)
- B. Medullary thyroid carcinoma
- C. Parathyroid adenoma
- D. Vitamin D resistant rickets
Physiological Biomarkers Explanation: **Sepsis**
- **Procalcitonin** (PCT) levels significantly rise in response to bacterial infections and **sepsis**, making it a useful diagnostic and prognostic marker.
- Its levels correlate with the severity of bacterial infection and can help differentiate bacterial from viral etiologies.
*Medullary thyroid carcinoma*
- **Medullary thyroid carcinoma** (MTC) is characterized by the production of **calcitonin**, a different hormone from procalcitonin, by the parafollicular C cells of the thyroid.
- While calcitonin is a tumor marker for MTC, **procalcitonin** is not.
*Vitamin D resistant rickets*
- **Vitamin D resistant rickets** (also known as X-linked hypophosphatemia) is a genetic disorder characterized by impaired phosphate reabsorption in the kidneys [1].
- It is associated with low phosphate levels and bone deformities, but not with elevated procalcitonin [1].
*Parathyroid adenoma*
- A **parathyroid adenoma** leads to primary hyperparathyroidism, characterized by excessive production of **parathyroid hormone (PTH)** [1].
- This results in hypercalcemia and hypophosphatemia, with no direct link to procalcitonin levels [1].
Physiological Biomarkers Indian Medical PG Question 8: Which of the following is the most accurate measure of Glomerular Filtration Rate (GFR)?
- A. Cystatin C
- B. Serum creatinine
- C. Creatinine Clearance
- D. Iothalamate Clearance (Correct Answer)
Physiological Biomarkers Explanation: ***Iothalamate Clearance***
- **Iothalamate clearance** is considered the **gold standard** for directly measuring GFR in clinical practice because it is a substance that is freely filtered by the glomerulus and is neither reabsorbed nor secreted by the renal tubules.
- This method provides the most accurate and precise assessment of kidney function by quantifying the actual GFR, often used in research settings or for precise diagnosis.
- **Note:** Inulin clearance is the traditional reference standard, but iothalamate is more practical and widely used clinically as it can be measured using radioactive or non-radioactive methods.
*Serum creatinine*
- **Serum creatinine** is a commonly used biomarker but is an **imperfect measure** of GFR because it can be influenced by factors like muscle mass, diet, and certain medications.
- Its levels can remain within the normal range even when GFR has significantly decreased, especially in the early stages of kidney disease.
*Cystatin C*
- **Cystatin C** is a protein produced by most nucleated cells and is also freely filtered by the glomerulus, with less influence from muscle mass and diet compared to creatinine.
- While considered a better marker than serum creatinine, it is still an **estimated measure** and is more expensive and less widely available than creatinine, and can be affected by inflammation or thyroid dysfunction.
*Creatinine Clearance*
- **Creatinine clearance** (often estimated using urine and serum creatinine levels over a timed collection) attempts to approximate GFR but can be **inaccurate** due to incomplete urine collection and tubular secretion of creatinine.
- The **creatinine secretion** by the renal tubules leads to an overestimation of the true GFR, making it less accurate than direct measurement methods.
Physiological Biomarkers Indian Medical PG Question 9: What is the recommended daily calcium intake for adult non-pregnant females?
- A. 1000 mg (Correct Answer)
- B. 1200 mg
- C. 600 mg
- D. 800 mg
Physiological Biomarkers Explanation: ***1000 mg***
- The recommended daily calcium intake for adult non-pregnant females (ages 19-50) is **1000 mg** according to **WHO and international guidelines** (US RDA/NIH) to maintain bone health and prevent osteoporosis.
- This is the **standard recommendation** used in most medical textbooks and international nutritional guidelines.
- Adequate calcium intake supports various bodily functions, including **nerve transmission**, **muscle contraction**, and **hormone secretion**.
*1200 mg*
- While 1200 mg is the recommended intake for **older women (above 50-70 years)** or during **pregnancy/lactation** per some guidelines, it is generally higher than necessary for non-pregnant adult females aged 19-50.
- While not harmful, this higher dose is not specifically indicated for the general non-pregnant adult female population.
*600 mg*
- This amount of calcium is **lower than the internationally recommended daily allowance** for adult women (though it aligns with some regional guidelines like ICMR for sedentary women).
- For optimal bone health and prevention of osteoporosis, **1000 mg is the widely accepted standard** in medical education.
*800 mg*
- This value is **below the internationally recommended daily intake** for adult non-pregnant females, which could lead to long-term calcium deficiency.
- Insufficient calcium intake can increase the risk of conditions like **osteopenia** and **osteoporosis**.
Physiological Biomarkers Indian Medical PG Question 10: Insulin-like growth factor is secreted by:
- A. Liver (Correct Answer)
- B. Pituitary gland
- C. Pancreas
- D. Adrenal glands
Physiological Biomarkers Explanation: ***Liver***
- The **liver** is the primary site of **insulin-like growth factor 1 (IGF-1)** production in response to **growth hormone (GH)** stimulation.
- IGF-1 mediates many of the growth-promoting effects of GH, affecting various tissues throughout the body.
*Pituitary gland*
- The **pituitary gland** secretes **growth hormone (GH)**, which then stimulates the liver to produce IGF-1, but it does not directly secrete IGF-1.
- Its role is upstream in the GH-IGF-1 axis, initiating the signaling cascade.
*Pancreas*
- The **pancreas** is primarily known for secreting **insulin** and **glucagon**, which regulate blood glucose levels.
- It does not produce significant amounts of IGF-1.
*Adrenal glands*
- The **adrenal glands** produce hormones like **cortisol**, **aldosterone**, and **androgens**.
- They are not involved in the direct secretion of IGF-1.
More Physiological Biomarkers Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
টাকেjson